All data are based on the daily closing price as of September 15, 2025
g
GemVax&KAEL
082270.KQ
35.32 USD
-3.09
-8.04%
Overview
Last close
35.32 usd
Market cap
1.26B usd
52 week high
51.11 usd
52 week low
7.31 usd
Target price
N/A usd
Valuation
P/E
N/A
Forward P/E
N/A
Price/Sales
31.2732
Price/Book Value
53.6414
Enterprise Value
1.62B usd
EV/Revenue
32.8529
EV/EBITDA
-173.0774
Key financials
Revenue TTM
56.85M usd
Gross Profit TTM
13.45M usd
EBITDA TTM
1.66M usd
Earnings per Share
N/A usd
Dividend
N/A usd
Total assets
119.93M usd
Net debt
N/A usd
About
GemVax&KAEL Co.,Ltd engages in the manufacturing and commercializing of resins and filters for semi-conductor and panel display production in South Korea. The company offers impregnated active carbon and inorganic adsorbent coating resins; CA filter for removing chemical pollution substances and harmful gases in semiconductor and LCD/PDP manufacturing process; adsorbent towers for air pollution prevention; and pressure facility for preventing equipment erosion within a substation; and 5aver, a fire evacuation mask. It also engages in the research and development of anti-cancer immunotherapeutic and peptide drugs; and provides RIAVAX, an immunotherapeutic peptide for the treatment of locally advanced or metastatic pancreatic cancer. The company was founded in 1998 and is headquartered in Daejeon, South Korea.